June 24th 2025
mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.
February 17th 2025
FDA Approves New Influenza Vaccine Manufactured with Novel Technology
January 18th 2013FDA has approved Protein Sciences's FluBlok, a seasonal influenza vaccine made with novel technology. FluBlok uses recombinant DNA and a modified baculovirus (a virus that infects insects) to produce a safe and effective human flu vaccine. FDA approved Flublok for people 18–49 years old.
Determining Potency of Preclinical Dose Formulations
October 2nd 2012Potency is a required measurement to determine the amount of active ingredient contained in a preclinical dose formulation. Assessing potency ensures that the test system receives the appropriate amount of active ingredient based on predetermined specifications.
FLUID-BAG MULTI — superior logistics for liquid and semi-solid pharmaceutical products
October 2nd 2012Fluid-Bag Ltd provides comprehensive 900 and 1000 litre flexible IBC systems for liquid and semi-solid products, including filling and discharging equipment. The GMP compliant container system is designed to guarantee uniform liquid, maximise payload and minimise discharge residue (0.5% residue).